Big pharma companies like Moderna, Pfizer, and Novavax are preparing for the newest COVID “vaccine” rollout coming this fall. The United States Food and Drug Administration’s Covid strain selection for the next round of shots is a decisive win for the companies creating and pushing these injections on the public.
On Friday, the FDA advised the three aforementioned companies to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5, one of the most “immune-evasive” COVID variants to date, if you “trust the science” and those asserting said science. The XBB.1.5 strain accounted for nearly 40% of all Covid cases in the U.S. in early June, but that proportion is slowly declining, according to data from the Centers for Disease Control and Prevention.
But the “vaccines” have so far been epic failures. In fact, the Centers for Disease Control and Prevention has even admitted that those who get “vaccinated” are more likely to be infected with the XBB1.5 variant.
Pfizer said Thursday it will be able to deliver a shot targeting XBB.1.5 by July. Moderna and Novavax did not provide specific timelines for their versions.
Shots targeting XBB.1.5 seem “the most feasible to get across the finish line early without resulting in delays in availability,” Dr. Melinda Wharton, a senior official at the National Center for Immunization and Respiratory Diseases, said at an FDA advisory committee meeting Thursday, according to a report by CNBC.
The U.S. is expected to shift Covid vaccine distribution to the private sector as soon as the fall, when the federal government’s supply of free shots is expected to run out. Manufacturers will sell their updated jabs directly to health-care providers rather than to the government. –CNBC
The booster shots or annual jabs are having a major messaging problem too. Only around 17% of the U.S. population (around 56 million people) have been naive enough to receive Pfizer and Moderna’s latest boosters since they were approved in September, according to the CDC.
That could mean we’ll see an increase in the vaccine propaganda to try to convince the public they need never-ending shots to stave off that pesky common cold.